Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DPACE-based chemotherapy in the era of myeloma novel agents: A UK multicentre study.
Djebbari F, De Abrew K, Salhan B, Panitsas F, Hossain MI, Eyre TA, Willan J, Ramasamy K, Basu S, Jenner M, Kothari J. Djebbari F, et al. Among authors: salhan b. Eur J Haematol. 2020 Aug;105(2):231-233. doi: 10.1111/ejh.13422. Epub 2020 Apr 21. Eur J Haematol. 2020. PMID: 32268442 No abstract available.
Infections in relapsed myeloma patients treated with isatuximab plus pomalidomide and dexamethasone during the COVID-19 pandemic: Initial results of a UK-wide real-world study.
Djebbari F, Rampotas A, Vallance G, Panitsas F, Basker N, Sangha G, Salhan B, Karim F, Firas AK, Gudger A, Ngu L, Poynton M, Lam HPJ, Morgan L, Yang L, Young J, Walker M, Tsagkaraki I, Anderson L, Chauhan SR, Maddams R, Soutar R, Triantafillou M, Prideaux S, Obeidalla A, Eyre TA, Bygrave C, Basu S, Ramasamy K. Djebbari F, et al. Among authors: salhan b. Hematology. 2022 Dec;27(1):691-699. doi: 10.1080/16078454.2022.2082725. Hematology. 2022. PMID: 35666686 Free article.
Efficacy of Isatuximab With Pomalidomide and Dexamethasone in Relapsed Myeloma: Results of a UK-Wide Real-World Dataset.
Djebbari F, Rampotas A, Vallance G, Panitsas F, Basker N, Sangha G, Salhan B, Karim F, Al-Kaisi F, Gudger A, Ngu L, Poynton M, Lam HPJ, Morgan L, Yang L, Young J, Walker M, Tsagkaraki I, Anderson L, Chauhan SR, Maddams R, Soutar R, Triantafillou M, Prideaux S, Obeidalla A, Bygrave C, Basu S, Ramasamy K. Djebbari F, et al. Among authors: salhan b. Hemasphere. 2022 May 26;6(6):e738. doi: 10.1097/HS9.0000000000000738. eCollection 2022 Jun. Hemasphere. 2022. PMID: 35651713 Free PMC article.
SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study.
Shields AM, Venkatachalam S, Shafeek S, Paneesha S, Ford M, Sheeran T, Kelly M, Qureshi I, Salhan B, Karim F, De Silva N, Stones J, Lee S, Khawaja J, Kaudlay PK, Whitmill R, Kakepoto GN, Parry HM, Moss P, Faustini SE, Richter AG, Drayson MT, Basu S. Shields AM, et al. Among authors: salhan b. Clin Exp Immunol. 2022 Jan 28;207(1):3-10. doi: 10.1093/cei/uxab018. Clin Exp Immunol. 2022. PMID: 35020852 Free PMC article.
COVID-19 in bone marrow transplant recipients: reflecting on a single centre experience.
Kanellopoulos A, Ahmed MZ, Kishore B, Lovell R, Horgan C, Paneesha S, Lloyd R, Salhan B, Giles H, Chauhan S, Venkatadasari I, Khakwani M, Murthy V, Xenou E, Dassanayake H, Srinath S, Kaparou M, Nikolousis E. Kanellopoulos A, et al. Among authors: salhan b. Br J Haematol. 2020 Jul;190(2):e67-e70. doi: 10.1111/bjh.16856. Epub 2020 Jun 23. Br J Haematol. 2020. PMID: 32469077 Free PMC article. No abstract available.
Management of Allogeneic Stem Cell Transplantation for High-Risk AML following SARS-CoV-2 Associated Pancytopenia with Marked Bone Marrow Biopsy Alterations.
Kaparou M, Rudzki Z, Giles H, Murthy V, Srinath S, Lloyd R, Ahmed MZ, Salhan B, Chauhan S, Kishore B, Lovell R, Horgan C, Paneesha S, Xenou E, Lokare A, Ewing J, Dassanayake H, Nikolousis E, Kanellopoulos A. Kaparou M, et al. Among authors: salhan b. Case Rep Hematol. 2021 Jan 21;2021:8843063. doi: 10.1155/2021/8843063. eCollection 2021. Case Rep Hematol. 2021. PMID: 33510919 Free PMC article.
Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK-wide real-world cohort of relapsed myeloma patients.
Djebbari F, Rampotas A, Vallance G, Panitsas F, Basker N, Sangha G, Salhan B, Karim F, Al-Kaisi F, Gudger A, Ngu L, Poynton M, Lam HPJ, Morgan L, Yang L, Young J, Walker M, Tsagkaraki I, Anderson L, Chauhan SR, Maddams R, Soutar R, Triantafillou M, Prideaux S, Obeidalla A, Eyre TA, Bygrave C, Kothari J, Basu S, Ramasamy K. Djebbari F, et al. Among authors: salhan b. Br J Haematol. 2023 Apr;201(1):162-167. doi: 10.1111/bjh.18672. Epub 2023 Jan 31. Br J Haematol. 2023. PMID: 36720464 No abstract available.